News
(2)April 2026
Spyre Therapeutics (SYRE) Files Annual Report to Shareholders
# 🔍 First, A Quick Reality Check Hello! I've got your request to summarize the SEC filing for Spyre Therapeutics (SYRE). However, the document text you provided is just a placeholder (`<PDF>` tag) with **no actual filing content** inside it. An ARS (Annual Report to Shareholders) is typically a co
SYRE Shareholders Vote on Directors Auditor and Stock Plan
# 🧾 What This Document Is This is a **DEF 14A**, also known as a **Proxy Statement**. Think of it as an invitation and instruction manual for a company's annual shareholder meeting. Spyre Therapeutics is asking its owners (the shareholders) to vote on several important company decisions. It outline
Peers in Biotechnology
Vertex Pharmaceuticals Incorporated
Regeneron Pharmaceuticals, Inc.
argenx SE
Alnylam Pharmaceuticals, Inc.
BeOne Medicines AG
Insmed Incorporated
Royalty Pharma plc
BioNTech SE
Roivant Sciences Ltd.
Moderna, Inc.